Ectopic pregnancyMANAGEMENT

GENITOURINARY AND REPRODUCTIVE PRESENTATIONS · 12 SECTIONS

⚲

424 items

☷ Legend

⚲

Cardiovascular Presentations71▾

Respiratory Presentations52▾

Neurological Presentations83▾

Gastrointestinal Presentations74▾

Genitourinary and Reproductive Presentations48▾

Acute Kidney Injury (ATN)Acute Kidney Injury (Post-renal)Acute Kidney Injury (Pre-renal)Amniotic Fluid Embolism Balanitis Bladder Rupture Breast Abscess Cystitis Dialysis access complications Ectopic pregnancy Epididymitis Glomerulonephritis Hematuria (gross)Hydrocele Interstitial Cystitis Mastitis Mittelschmerz Nephrolithiasis Nephrotic Syndrome Flare Nutcracker Syndrome Orchitis Ovarian Cyst Rupture Ovarian hyperstimulation syndrome Ovarian torsion Paraphimosis Pelvic Congestion Syndrome Pelvic Inflammatory Disease (PID)Peritoneal dialysis peritonitis Phimosis Priapism Prostatitis Pyelonephritis Renal laceration Renal transplant complications and rejection Ruptured ovarian cyst Testicular torsion Torsion of Appendix Testis Tubo-ovarian abscess Ureteral Rupture Urethritis Urinary Retention Urinary tract infection (uncomplicated)Urolithiasis (renal colic)Vaginal bleeding (non-pregnant)Vaginitis (Bacterial)Vaginitis (Candidal)Varicocele Vulvovaginal Hematoma

Infectious Disease Presentations148▾

Trauma Presentations89▾

Toxicologic Presentations80▾

Psychiatric Presentations26▾

Musculoskeletal and Rheumatologic Presentations96▾

Dermatology Presentations23▾

Environmental and Exposure Presentations27▾

Hematologic and Oncologic Presentations36▾

Pediatric-Specific Presentations19▾

Endocrine and Metabolic Presentations45▾

ENT and Maxillofacial Presentations27▾

Ophthalmologic Presentations19▾

Obstetric Presentations23▾

Systemic and Miscellaneous Presentations17▾

01Approach to the Critical Patient/attcp32

Immediate priorities

›Hemodynamic instability and hemorrhage control

›If hypotension or syncope, resuscitation bay

›If ongoing shock, activate massive transfusion protocol

›If suspected rupture, immediate OB or GYN and anesthesia consultation

›Airway and breathing threats

›If altered mental status, airway management pathway

›Oxygen for hypoxemia

›Circulation support

›Two large bore IV or intraosseous access

›Crystalloid bolus while preparing blood products

›Bedside confirmation steps

›Urine pregnancy test or serum beta hCG

›Point of care ultrasound for free intraperitoneal fluid

Hemorrhage risk stratification

›Rupture risk and time critical triggers

›Peritoneal signs

›Rebound tenderness

›Guarding

›Hemodynamic compromise

›SBP < 90 mmHg

›Persistent tachycardia

›High risk ultrasound findings

›Moderate or large free fluid

›Adnexal mass with surrounding fluid

Consultation and escalation

›Early specialty involvement

›OB or GYN consultation for all suspected ectopic pregnancy

02History/hx40

Presenting features

›Symptom pattern and timing

›First trimester pelvic or abdominal pain

›Unilateral pain

›Shoulder tip pain

›Vaginal bleeding

›Light spotting

›Heavy bleeding

›Syncope or presyncope

›Postural symptoms

›Collapse episodes

Risk factors

›Predisposing history

›Prior ectopic pregnancy

›Recurrence risk

›Prior tubal surgery

›Tubal pathology

›Pelvic inflammatory disease

›Tubal infertility

›Conception context

›Assisted reproductive technology

›Intrauterine device in situ at conception

›Smoking

›Current tobacco use

›Heavy lifetime exposure

Pregnancy details

›Pregnancy dating and prior evaluation

›Last menstrual period

03Physical Exam/exam27

Vital signs and perfusion

›Hemodynamic assessment

›Blood pressure and heart rate trends

›Orthostatic change

›Persistent tachycardia

›Perfusion markers

›Cool extremities

›Delayed capillary refill

Abdominal and pelvic findings

›Abdominal exam domains

›Focal tenderness

›Unilateral lower quadrant pain

›Suprapubic tenderness

›Peritoneal irritation

›Rebound tenderness

›Guarding

›Pelvic exam domains

›Cervical motion tenderness

›PID overlap

›Ectopic possible

›Adnexal tenderness or mass

›Limited sensitivity

›Correlate with ultrasound

›Vaginal bleeding source

›Cervical lesions

›Products of conception at os

Pitfalls

›Normal pelvic exam does not exclude ectopic pregnancy

04Differential Diagnosis/ddx38

Life threatening and time critical

›Emergencies in early pregnancy

›Ectopic pregnancy, tubal, ovarian, cervical, cornual, cesarean scar

›ICD-10 O00.0 tubal pregnancy

›ICD-10 O00.1 ovarian pregnancy

›ICD-10 O00.2 abdominal pregnancy

›Ruptured hemorrhagic ovarian cyst

›Hemoperitoneum

›Acute anemia

›Ovarian torsion

›Sudden severe pain

›Vomiting

›Appendicitis

›Migratory pain

›Fever or leukocytosis

Mimics and common alternatives

›Early pregnancy bleeding causes

›Threatened abortion

›Closed cervix

›Viable intrauterine pregnancy

›Spontaneous abortion

›Open os

›Products of conception

›Gestational trophoblastic disease

›Very high beta hCG

›Hyperemesis or early preeclampsia

›Nonpregnancy gynecologic

›Pelvic inflammatory disease

05Laboratory Tests/lt28

Core tests

›Pregnancy and bleeding risk labs

›Serum beta hCG quantitative

›Baseline for trends

›Interpretation paired with ultrasound timing

›Complete blood count for bleeding concern

›Baseline hemoglobin

›Leukocytosis nonspecific

›Type and screen

›Rh(D) status

›Crossmatch if unstable or suspected rupture

Adjunct tests

›Infection and alternative diagnosis

›Urinalysis

›UTI mimic

›Hematuria for stone

›NAAT for chlamydia and gonorrhea when PID possible

›Supports alternate diagnosis

›Does not exclude ectopic

Interpretation pearls

›Beta hCG trend logic for pregnancy of unknown location

›Typical viable intrauterine pregnancy rise over 48 hours

›Suboptimal rise increases ectopic risk

›Ectopic can rise normally early

›Falling beta hCG

›Failing pregnancy more likely

›Ectopic can still rupture during decline

06Diagnostic Tests/dt54

Scoring Systems

›Pregnancy of unknown location risk frameworks

›Clinical risk stratification

›Hemodynamic stability

›Pain severity and peritoneal signs

›Serial beta hCG with ultrasound algorithm

›Repeat beta hCG in 48 hours

›Repeat transvaginal ultrasound based on trend and symptoms

›High risk triggers for immediate intervention

›Instability

›Significant free fluid

MRI

›MRI use in pregnancy related pelvic pain

›Indications when ultrasound nondiagnostic

›Suspected appendicitis

›Complex adnexal mass

›Safety considerations

›Noncontrast MRI preferred

›Avoid gadolinium unless essential

›Limitations for ectopic confirmation

›Not first line for ectopic

›Availability delays

›CT in early pregnancy

›General avoidance due to ionizing radiation

›Use only if maternal life threatened and alternative imaging unavailable

›Shared decision making when time allows

›Ectopic specific limitation

07Disposition/dispo24

Level of care decisions

›Admission and operative management

›Ruptured ectopic pregnancy criteria

›Hemodynamic instability

›Peritoneal signs

›Nonruptured ectopic needing surgery

›Contraindications to methotrexate

›Inability to ensure follow up

›Observation and close follow up

›Pregnancy of unknown location

›Stable vital signs

›Reliable follow up in 48 hours

›Suspected early intrauterine pregnancy

›No red flags

›Clear return precautions

Discharge requirements

›Safe outpatient pathway

›Stable vital signs with reassuring exam

›No peritoneal signs

›Pain controlled

›Follow up logistics confirmed

›Serial beta hCG plan

›Repeat ultrasound plan

›Clear return precautions documented

›Worsening pain

›Syncope or heavy bleeding

08Treatment/t97

Resuscitation and hemorrhage control

›Immediate stabilization

›IV fluids and blood products

›Packed red blood cells for hemorrhagic shock

›Balanced transfusion strategy per local protocol

›Analgesia

›Acetaminophen

›Opioid titration for severe pain

›Antiemetics

›Ondansetron

›Metoclopramide

Rh(D) immune globulin

›Alloimmunization prevention

›Rh negative and any bleeding or pregnancy loss concern

›Rh(D) immune globulin per local dosing protocol

›Timing within 72 hours when possible

›Documentation

›Rh status result

›Dose and time given

Medical management with methotrexate

›Candidate selection

›Hemodynamic stability

›No evidence of rupture

›No significant free fluid

›Follow up reliability

›Serial beta hCG visits

›Return precautions understanding

›Favorable disease factors

›Low and declining or low plateau beta hCG

›Small ectopic mass size

›Contraindications

›Absolute contraindications

›Hemodynamic instability or suspected rupture

›Breastfeeding

›Immunodeficiency

›Significant hepatic disease

›Hematologic and renal contraindications

›Moderate or severe anemia

›Leukopenia

›Thrombocytopenia

›Significant renal impairment

›Pulmonary and GI contraindications

›Active pulmonary disease

›Peptic ulcer disease

›Single dose regimen

›Methotrexate IM 50 mg per m2

›Day 1 dosing

›Baseline beta hCG and labs

›Monitoring schedule

›Beta hCG day 4

›Beta hCG day 7

›Response criterion

›If day 4 to day 7 decrease < 15 percent, repeat dose or surgical evaluation

›If appropriate decline, weekly beta hCG until negative

›Two dose regimen

›Methotrexate IM 50 mg per m2

›Day 1 dosing

›Day 4 dosing

›Monitoring schedule

›Beta hCG day 4

›Beta hCG day 7

›Response criterion

›If inadequate decline, additional dose or surgery per protocol

›Patient counseling and safety

›Avoid folic acid supplements during treatment

›Reduced methotrexate effectiveness

›Resume after completion per clinician guidance

›Avoid alcohol

›Hepatotoxicity risk

›Dehydration risk

›Avoid NSAIDs if advised by treating team

›Drug interaction concern

›Follow local protocol

›Avoid intercourse and vigorous exercise until resolution

›Rupture risk while healing

›Bleeding risk

Surgical management

›Indications

›Rupture suspicion

›Instability

›Significant free fluid

›Methotrexate failure

›Rising or plateau beta hCG after treatment

›Persistent pain with concern for rupture

›Contraindications to methotrexate

›Organ disease

›Follow up barriers

›Approaches

›Laparoscopy preferred when stable

›Salpingostomy

›Salpingectomy

›Laparotomy for instability

›Rapid hemorrhage control

›Damage control principles

Evidence and recommendations

›Guideline aligned management statements

›Suspected ruptured ectopic pregnancy, immediate surgical management, Class I recommendation

›Maternal life threat

›Delay increases mortality

›Methotrexate appropriate for selected stable patients, Class I recommendation

›Requires reliable follow up

›Shared decision making

09Special Populations/sp24

Pregnancy

›Early pregnancy safety and diagnostic nuance

›Heterotopic pregnancy risk

›Assisted reproductive technology increases risk

›Intrauterine pregnancy does not exclude ectopic in ART

›Imaging choices

›Transvaginal ultrasound first line

›MRI noncontrast for alternate diagnoses when needed

›Medication considerations

›Avoid teratogens when intrauterine pregnancy not excluded

›Methotrexate only after ectopic diagnosis or high certainty and plan

Geriatric

›Advanced maternal age and atypical presentations

›Lower clinical suspicion risk

›Perimenopausal bleeding confusion

›Delayed pregnancy recognition

›Comorbidity impact

›Higher surgical risk

›Medication contraindications more common

Pediatrics

›Adolescent pregnancy considerations

›Confidentiality and consent laws

›Local policy adherence

›Guardian involvement when appropriate

›Higher STI risk

›PID as risk factor

›Concurrent STI testing and treatment planning

10Background/b28

Epidemiology

›Frequency and outcomes

›Incidence about 1 to 2 percent of reported pregnancies

›Leading cause of first trimester maternal mortality in many settings

›Mortality reduced with early diagnosis

›Common location

›Tubal ectopic most common

›Ampullary segment common site

Pathophysiology

›Mechanisms of abnormal implantation

›Delayed ovum transport

›Tubal inflammation and scarring

›Ciliary dysfunction from smoking

›Implantation and trophoblastic invasion

›Local vascular erosion

›Hemoperitoneum when rupture occurs

›Pregnancy of unknown location states

›Very early intrauterine pregnancy below detection

›Early failing pregnancy

›Ectopic pregnancy not yet visualized

Therapeutic Considerations

›Treatment selection logic

›Surgery prioritized for rupture or instability

›Definitive hemorrhage control

›Rapid resolution

›Methotrexate for selected stable cases

›Cytotoxic effect on trophoblast

›Requires follow up until beta hCG negative

11Patient Discharge Instructions/pdi17

Copy discharge instructions

›Discharge instructions for suspected ectopic pregnancy or pregnancy of unknown location

›Return now for any red flags

›Severe or worsening abdominal or pelvic pain

›Shoulder tip pain

›Fainting, dizziness, or weakness

›Heavy vaginal bleeding

›Follow up plan

›Repeat beta hCG in 48 hours unless different plan given

›Repeat ultrasound as scheduled

›Activity guidance

›Avoid heavy lifting and strenuous exercise until cleared

›Avoid intercourse until cleared

›If treated with methotrexate

›Keep all beta hCG checks until told to stop

›Avoid alcohol

›Avoid folic acid supplements unless instructed otherwise

›Avoid pregnancy until cleared by treating team

12References/r15

Clinical guidelines and evidence sources

›Professional society guidance

›ACOG Practice Bulletin on tubal ectopic pregnancy and methotrexate management

›Candidate selection and contraindications

›Follow up beta hCG protocols

›RCOG guideline on diagnosis and management of ectopic pregnancy

›Pregnancy of unknown location approach

›Medical versus surgical selection

›Imaging consensus

›Society of Radiologists in Ultrasound consensus on first trimester ultrasound terminology and ectopic pregnancy findings

›Intrauterine pregnancy confirmation criteria

›Pseudosac discussion

›Emergency medicine practice support

›ACEP recommendations on evaluation of early pregnancy bleeding and pelvic pain

›Ultrasound as primary diagnostic test

›Serial beta hCG and repeat imaging for pregnancy of unknown location

Evidence & Review

Reviewed by SymptomDx Medical Team · Last reviewed August 18, 2026

SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.